Impaired function of α2-adrenergic autoreceptors on sympathetic nerves associated with mesenteric arteries and veins in DOCA-salt hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 4 55-4, 2004, Pages

  Luo, Min ^a   Fink, Gregory D ^a   Lookingland, Keith J ^a   Morris, John A ^a   Galligan, James J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ATP; Norepinephrine; Splanchnic circulation; Vasoconstriction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AUTORECEPTOR; BRIMONIDINE; DEOXYCORTICOSTERONE ACETATE; NORADRENALIN; YOHIMBINE; ADENINE NUCLEOTIDE; ADENOSINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DEOXYCORTICOSTERONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; MALE; MESENTERIC ARTERY; MESENTERIC VEIN; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RAT STRAIN; SPLANCHNIC BLOOD FLOW; SYMPATHETIC NERVE; VASOCONSTRICTION; ADRENERGIC SYSTEM; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROCHEMISTRY; INNERVATION; METABOLISM; MUSCLE TONE; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT;

ADENINE NUCLEOTIDES; ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AUTORECEPTORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESOXYCORTICOSTERONE; ELECTRIC STIMULATION; ELECTROCHEMISTRY; HYPERTENSION; MESENTERIC ARTERIES; MESENTERIC VEINS; MUSCLE TONUS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SODIUM CHLORIDE; SPECTROMETRY, FLUORESCENCE; SYMPATHETIC NERVOUS SYSTEM;

EID: 1642303776     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00592.2003     Document Type: Article

References (32)

1. Bobalova J and Mutafova-Yambolieva VN. Co-release of endogenous ATP and noradrenaline from guinea-pig mesenteric veins exceeds co-release from mesenteric arteries. Clin Exp Pharmacol Physiol 28: 397-401, 2001.
2. 2-adrenoceptor-mediated modulation of adenosine 5′ triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein. J Auton Pharmacol 21: 47-55, 2001.
3. Bohmann C, Rump LC, Schaible U, and von Kugelgen I. Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 25: 1224-1231, 1995.
4. Browning K, Zheng Z, Kreulen D, and Travagli R. Two populations of sympathetic neurons project selectively to mesenteric artery or vein. Am J Physiol Heart Circ Physiol 276: H1263-H1272, 1999.
5. Burnstock G and Sneddon P. Evidence for ATP and noradrenaline as cotransmitters in sympathetic nerves. Clin Sci (Lond) 68, Suppl 10: 89s-92s, 1985.
6. Cassis LA, Stitzel RE, and Head RJ. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp Ther 234: 792-803, 1985.
7. Cheung DW. Vascular neuroeffector mechanisms in hypertension. Can J Physiol Pharmacol 67: 1146-1150, 1989.
8. De Champlain J. Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens Suppl 8: S77-S85, 1990.
9. Evans R and Surprenant A. Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmatol 106: 242-249, 1992.
10. Fink GD, Johnson RJ, and Galligan JJ. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension 35: 464-469, 2000.
11. Foucart S, Nadeau R, and de Champlain J. The release of catecholamines from the adrenal medulla and its modulation by alpha 2-adreoceptors in the anaesthetized dog. Can J Physiol Pharmacol 65: 550-557, 1987.
12. Gitterman DP and Evans RJ. Nerve evoked P2X receptor constrictions of rat mesenteric arteries; dependence on vessel size and lack of role of L-type calcium channels and calcium- induced calcium release. Br J Pharmacol 132: 1201-1208, 2001.
13. Greenway C. Role of splanchnic venous system in overall cardiovascular homeostasis. Fed Proc 42: 1678-1684, 1983.
14. Hottenstein O and Kreulen DL. Comparison of the frequency dependence of venous and arterial responses to sympathetic nerve stimulation in guinea pigs. J Physiol 384: 153-167, 1987.
15. Kreulen DL. Activation of mesenteric arteries and veins by preganglionic and postganglionic nerves. Am J Physiol Heart Circ Physiol 251: H1267-H1275, 1986.
16. Lamprecht F, Richardson JS, Williams RB, and Kopin IJ. 6-Hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats. J Neural Transm 40: 149-58, 1977.
17. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32: 37-62, 1980.
18. Levitt B, Head RJ, and Westfall DP. High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vasdeferens. Anal Biochem 137: 93-100, 1984.
19. Luo M, Hess MC, Fink GD, Olson KL, Rogers J, Kreulen DL, Dai X, and Galligan JJ. Differential alterations in sympathetic neurotransmission in mesenteric arteries and veins in DOCA-salt hypertensive rats. Auton Neurosci 104: 47-57, 2003.
20. Mangiarua EI and Lee RM. Increased sympathetic innervation in the cerebral and mesenteric arteries of hypertensive rats. Can J Physiol Pharmacol 68: 492-499, 1990.
21. Monos E, Berczi V, and Nadasy G. Local control of veins: biochemical metabolic and humoral aspects. Physiol Rev 75: 611-666, 1995.
22. Moreau P, Drolet G, Yamaguchi N, and de Champlain J. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. Am J Hypertens 8: 287-293, 1995.
23. Nyhof RA, Laine GA, Meininger GA, and Granger HJ. Splanchnic circulation in hypertension. Fed Proc 42: 1690-1693, 1983.
24. Rump LC, Wilde K, and Schollmeyer P. Prostaglandin E2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats. J Hypertens 8: 897-908, 1990.
25. Schobel H, Schmeider RE, Gatzka CD, and Messerli FH. A centripedal shift in intravascular volume triggers the onset of early cardiac adaptation in hypertension. J Hypertens 11, Suppl 5: S94-S95, 1993.
26. a. Schnek J and McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods 27: 161-170, 1992.
27. Sneddon P, Meldrum LA, and Burnstock G. Control of transmitter release in guinea-pig vas deferens by prejunctional P1-purinoceptors. Eur J Pharmacol 105: 293-299, 1984.
28. Tabei R, Kondo M, Terada M, Miyazaki T, Watanabe Y, Shimizu D, and Yamamoto I. Noradrenergic hyperinnervation in the caval vein of stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22: S73-S74, 1995.
29. Trendelenburg AU, Norenberg W, Hein L, Meyer A, and Starke K. Alpha2-adrenoceptor-mediated inhibition of cultured sympathetic neurons: changes in alpha2A/D-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 363: 110-119, 2001.
30. Tsuda K, Tsuda S, Nishio I, and Masuyama Y. Inhibition of NE release by presynaptic alpha 2-adrenoceptors in mesenteric vasculature preparations from chronic DOCA-salt hypertensive rats. Jpn Heart J 30: 231-239, 1989.
31. Westfall TC, Carpentier S, Naes L, and Meldrum MJ. Comparison of NE release in hypertensive rats: II. Caudal artery and portal vein. Clin Exp Hypertens 8: 221-237, 1986.
32. Willems WJ, Harder DR, Contney SJ, McCubbin JW, and Stekiel WJ. Sympathetic supraspinal control of venous membrane potential in spontaneous hypertension in vivo. Am J Physiol Cell Physiol 243: C101-C106, 1982.